1. FDA approves first generic for Amarin's Vascepa — Roche buys Stratos Genomics to improve diagnostic arm — Intercept's NASH drug hits regulatory snag at FDA — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

CNS Therapeutics

Discussion in 'Neurology' started by Anonymous, May 10, 2012 at 2:49 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Has any one heard about this company? A recruiter called me to sell their generic injection.
     

  2. Anonymous

    Anonymous Guest

    A well-funded private company with a great CEO and growing revenues, market share and pipeline of products coming next few years. Demanding sales quotas but good incentives for performance...